Last reviewed · How we verify

Carafate — Competitive Intelligence Brief

Carafate (Carafate) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Aluminum Complex [EPC]. Area: Pain.

marketed Aluminum Complex [EPC] Pepsin A-5 Pain Small molecule Live · refreshed every 30 min

Target snapshot

Carafate — Forest Labs Inc.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Carafate TARGET Carafate Forest Labs Inc marketed Aluminum Complex [EPC] Pepsin A-5 1981-01-01
Carafate sucralfate Generic (originally Marion Merrell Dow) marketed Aluminum Complex [EPC] Pepsin A-5 1981-10-30

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Aluminum Complex [EPC] class)

  1. Forest Labs Inc · 1 drug in this class
  2. Generic (originally Marion Merrell Dow) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Carafate — Competitive Intelligence Brief. https://druglandscape.com/ci/carafate. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: